NSC |
Compound |
Enrichment |
Correlation |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0129421834592789 |
0.042892043 |
NSC 725098 |
Null |
0.0129421834592789 |
0.27110488 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0129421834592789 |
0.17635931 |
NSC 753598 |
Null |
0.0129421834592789 |
0.21776658 |
NSC 762908 |
2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one |
0.012942183459279 |
0.21885913 |
NSC 302288 |
BOHLMANN K2630 |
0.0133012546828912 |
0.23632909 |
NSC 343378 |
1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- |
0.0133012546828912 |
0.095016608 |
NSC 526333 |
2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime |
0.0133012546828912 |
0.24038564 |
NSC 59996 |
Benzaldehyde, 2-amino-, phenylhydrazone (9CI) |
0.0133012546828912 |
0.33328227 |
NSC 642408 |
Null |
0.0133012546828912 |
0.033779707 |